Tue, Jul 22, 2014, 6:32 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Progenics Pharmaceuticals, Inc. Message Board

  • bioimmunomabman bioimmunomabman May 7, 2009 11:29 AM Flag

    Another new 52-week low

    Looks like shorts are probably aiming to take out the $5 stops and try to force margin calls. PGNX has been a regular on the 52-week low list the past few days. Might be a good trade opportuity to put in a low bid $4.5 to $4.74 area in case they hit the stops. I doubt it's going a whole low lower from here unless the burn is really bad and they fail to make cuts.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Don;t worry--their are folks at PGNX who read this . Most companies of this size have a few people reviewing these types of threads--either formally or informally.

    • bio - this is really a tough pill to swallow here .... MNTX medication works etc but there are issues with packaging and pricing and promoting Relistor.

      If i thought it would help i would send them my thoughts as a layperson who has taken entereg, and know a fair amount about MNTX, and a lot about OIC/OBD. If i do send a note to the BOD, these are the folks i would send it to Using 1st initial and last name @progenics.com:

      Mr. Mark R. Baker J.D.
      Executive Vice President - Corporate

      Kurt W. Briner
      Chairman of the Board

      Richard W. Krawiec, PhD
      Vice President, Corporate Affairs
      Progenics Pharmaceuticals, Inc.
      777 Old Saw Mill River Rd.
      Tarrytown, NY 10591
      T: 914-789-2814
      F: 914-789-2884

      thouhgts/input welcome ... regards

 
PGNX
4.87-0.06(-1.22%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.